Ankara-Sana
The pharmaceutical sector in Turkey suffered heavy losses after the decline in the exchange rate of the Turkish lira and its decline to unprecedented levels against the US dollar.
Reuters quoted the leaders of the pharmaceutical sector and pharmacy chains as saying that "the pharmaceutical sector, which is worth 48 billion pounds, equivalent to four billion dollars, is incurring heavy losses in some products," warning of expected disruptions with several drugs in the coming months, including medicines for treating children's diseases, colds, sugar, high blood pressure. blood pressure.
The latest decline in the value of the Turkish currency exacerbated an already existing problem in the sector, which last year imported medicines worth 24 billion liras.
The Turkish currency recorded record lows in 11 consecutive sessions, bringing its losses since the beginning of this year to 43 percent, including about 24 percent incurred since the beginning of last week.
The continuous deterioration of the Turkish currency is mainly due to the repeated interventions of the Turkish President Recep Tayyip Erdogan in monetary policy and the rapid changes he imposed in the leadership of the Central Bank.